Aviva’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$521K Sell
9,435
-3,765
-29% -$208K ﹤0.01% 708
2025
Q1
$638K Sell
13,200
-1,427
-10% -$69K ﹤0.01% 661
2024
Q4
$565K Buy
+14,627
New +$565K ﹤0.01% 770